Company / Net Income
Ventyx Biosciences, Inc. Net Income History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$135.1M
FY2024
5-year range
-$193.0M / -$28.2M
FY2020-FY2024
Trend
+30.0%
vs FY2023
Sector context
#130 of 215
Health Care
What the data says
At -$135M, Ventyx Biosciences, Inc.'s net income ranks #130 of 215 in the Health Care sector. Net Income returned to growth in FY2024 after 3 years of decline, reaching -$135M.
Based on SEC 10-K filings.
-$135M in FY2024.
Declined from -$108M to -$135M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#130 of 215 in Health CareTop 60% of 215This company -$135.1M Sector average $431.3M
▼
-131.3% below sector average
Key checks
Key Insights
- In FY2024, net income increased 30.0% year-over-year.
- Ranks #130 out of 215 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$135.1M | +30.0% |
| FY2023 | -$193.0M | -78.0% |
| FY2022 | -$108.4M | -29.5% |
| FY2021 | -$83.7M | -197.2% |
| FY2020 | -$28.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026